146 related articles for article (PubMed ID: 15363484)
1. Blepharospasm associated with olanzapine: a case report.
Shimizu E; Otsuka A; Hashimoto K; Iyo M
Eur Psychiatry; 2004 Sep; 19(6):389. PubMed ID: 15363484
[No Abstract] [Full Text] [Related]
2. [Edema related to treatment with olanzapine].
Wustmann T; Fiedler T; Gutmann P
Psychiatr Prax; 2009 Apr; 36(3):142-4. PubMed ID: 18504690
[TBL] [Abstract][Full Text] [Related]
3. A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
Perez-Iglesias R; Crespo-Facorro B; Amado JA; Garcia-Unzueta MT; Ramirez-Bonilla ML; Gonzalez-Blanch C; Martinez-Garcia O; Vazquez-Barquero JL
J Clin Psychiatry; 2007 Nov; 68(11):1733-40. PubMed ID: 18052567
[TBL] [Abstract][Full Text] [Related]
4. [Acute catatonia: Questions, diagnosis and prognostics, and the place of atypical antipsychotics].
Belaizi M; Yahia A; Mehssani J; Bouchikhi Idrissi ML; Bichra MZ
Encephale; 2013 Jun; 39(3):224-31. PubMed ID: 23095594
[TBL] [Abstract][Full Text] [Related]
5. Is there a real difference in severity of tardive dyskinesia between risperidone and olanzapine?
Suzuki T; Takeuchi H; Watanabe K
J Clin Psychiatry; 2010 Nov; 71(11):1553-4; author reply 1554. PubMed ID: 21114953
[No Abstract] [Full Text] [Related]
6. Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease.
De Deyn PP; Carrasco MM; Deberdt W; Jeandel C; Hay DP; Feldman PD; Young CA; Lehman DL; Breier A
Int J Geriatr Psychiatry; 2004 Feb; 19(2):115-26. PubMed ID: 14758577
[TBL] [Abstract][Full Text] [Related]
7. Delusional wife: a case of diagnostic ambiguity and treatment challenge.
Ose BL; Pandurangi AK; Gorman JM
J Psychiatr Pract; 2005 May; 11(3):205-11. PubMed ID: 15920395
[No Abstract] [Full Text] [Related]
8. Olanzapine-associated bilateral eyelid edema.
Zink M; Kuwilsky A; Knopf U
J Clin Psychopharmacol; 2007 Apr; 27(2):214-5. PubMed ID: 17414232
[No Abstract] [Full Text] [Related]
9. Olanzapine-induced agranulocytosis in an adolescent male with psychosis.
Freedman JL; Ryan CA; Coffey BJ
J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):185-9. PubMed ID: 21504357
[No Abstract] [Full Text] [Related]
10. Monosymptomatic hypochondriacal psychosis: atypical presentation and response to olanzapine.
Chand PK; Anand S; Murthy P
J Clin Psychiatry; 2005 Jun; 66(6):800-1. PubMed ID: 15960578
[No Abstract] [Full Text] [Related]
11. Clozapine-induced tardive dystonia (blepharospasm).
Duggal HS; Mendhekar DN
J Neuropsychiatry Clin Neurosci; 2007; 19(1):86-7. PubMed ID: 17308236
[No Abstract] [Full Text] [Related]
12. Blepharospasm: an uncommon adverse effect caused by long-term administration of olanzapine.
Arora T; Maharshi V; Rehan HS; Nagar P
J Basic Clin Physiol Pharmacol; 2017 Jan; 28(1):85-87. PubMed ID: 27658142
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine-induced hyperprolactinemia and galactorrhea reversed with addition of bromocriptine: a case report.
Miller DE; Sebastian CS
J Clin Psychiatry; 2005 Feb; 66(2):269-70. PubMed ID: 15705020
[No Abstract] [Full Text] [Related]
14. Olanzapine versus risperidone: weight gain and elevation of serum triglyceride levels.
Garyfallos G; Dimelis D; Kouniakis P; Sidiropoulos N; Karastergiou A; Lavrentiadis G; Giouzepas J; Fokas K
Eur Psychiatry; 2003 Oct; 18(6):320-1. PubMed ID: 14611929
[No Abstract] [Full Text] [Related]
15. A case of venous thromboembolism probably associated with hyperprolactinemia after the addition of olanzapine to typical antipsychotics.
Toki S; Morinobu S; Yoshino A; Yamawaki S
J Clin Psychiatry; 2004 Nov; 65(11):1576-7. PubMed ID: 15554776
[No Abstract] [Full Text] [Related]
16. A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine.
Newcomer JW; Campos JA; Marcus RN; Breder C; Berman RM; Kerselaers W; L'italien GJ; Nys M; Carson WH; McQuade RD
J Clin Psychiatry; 2008 Jul; 69(7):1046-56. PubMed ID: 18605811
[TBL] [Abstract][Full Text] [Related]
17. [Olanzapine pamoate injection -- experience and case reports from Hungarian clinical practice].
Sümegi A; Kálmán J; Csekey L
Neuropsychopharmacol Hung; 2013 Jun; 15(2):105-17. PubMed ID: 23817361
[TBL] [Abstract][Full Text] [Related]
18. Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine.
Mulsant BH; Gharabawi GM; Bossie CA; Mao L; Martinez RA; Tune LE; Greenspan AJ; Bastean JN; Pollock BG
J Clin Psychiatry; 2004 Dec; 65(12):1708-14. PubMed ID: 15641877
[TBL] [Abstract][Full Text] [Related]
19. Reduction in tardive dyskinesia symptoms during treatment with olanzapine or haloperidol.
Kinon BJ; Kollack-Walker S; Stauffer V; Liu-Seifert H
J Clin Psychopharmacol; 2012 Jun; 32(3):420-2. PubMed ID: 22561475
[No Abstract] [Full Text] [Related]
20. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.
Crespo-Facorro B; Pérez-Iglesias R; Ramirez-Bonilla M; Martínez-García O; Llorca J; Luis Vázquez-Barquero J
J Clin Psychiatry; 2006 Oct; 67(10):1511-21. PubMed ID: 17107241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
